Thanks, Matt, and good morning. Second quarter revenue was $245 million above the midpoint of our guidance range and down 7% year-on-year. ASPs in the quarter declined slightly on a sequential basis. Unit volume was up sequentially. During the quarter, we saw strength in the Industrial and Commercial business unit, which ended at $165 million, up 15% from the same period of last year. All 3 segments of our I&C business performed well. In the Industrial segment, the connected equipment category was strong. In the commercial and retail space, we had a strong quarter. In electronic shelf labels and in smart cities, we saw strength in smart metering. The Home & Life business unit declined 33% year-over-year to end at $80 million. High levels of customer inventory continue to impact shipments for Home & Life. Geographically, during Q2, we saw the greatest strength in Europe, which was up 14% year-on-year. Revenue for APAC and the Americas was down year-on-year. Distribution revenue was 77% for the second quarter. That mix is down from the first quarter due to stronger shipments in Q2 to direct customers. DSI was stable in Q2 at 79 days. Our largest customer was under 4% of revenue in the quarter and our top 10 customers were about 24% of revenue, consistent with our historical results. Non-GAAP gross margin ended lower than expected at 58.9% on product mix. There were no price increases in the quarter, and we experienced no major changes in manufacturing input costs. The sequential decline in gross margin from the first quarter is largely due to the onetime effect of price increases at the beginning of this year, combined with product mix. Non-GAAP operating expenses were lower than we expected for the quarter, ending at $104 million. This was primarily due to lower variable costs based on our expectations for the year combined with specific favorable items such as lower fringe expenses in the quarter in the United States. Non-GAAP operating income was $40 million or 16.3% of sales. Our non-GAAP effective tax rate was slightly higher than we expected, the requirement to capitalize research and development costs for tax purposes continues to have an inflationary impact on our tax rate. We estimate that a normalized long-term non-GAAP effective tax rate without the effect of the R&D capitalization requirement would be in the high teens. Earnings per share on a non-GAAP basis ended slightly above the midpoint of our guidance range at $1.04, primarily on the upside in revenue and favorability in OpEx. On a GAAP basis, gross margin ended at 58.7%. GAAP operating expenses were $127 million. Our GAAP pretax income was favorable to the midpoint of our guidance range by around $3 million. However, due to the capitalization of R&D expenses and the timing of forecasted income for the year, our GAAP tax expense was unfavorable by about $5 million. Accordingly, GAAP earnings per share were $0.33 for the quarter, slightly below our guidance range. Turning on to the balance sheet. We ended the quarter with cash and investments of $506 million. Our accounts receivable balance grew in the quarter to $98 million, with days sales outstanding of 36 days. We added about $12 million in net inventory in the quarter to a total of $146 million as we continue to leverage the softer market to accumulate strategic die bank based on the strong design win momentum we've seen for the past few years. Inventory turns ended at 2.8x. During the second quarter, we finalized the redemption process on our 2025 convertible notes. As expected, we funded the par value of the notes, which was $535 million in cash. We settled the in-the-money component with shares, the total shares issued around 900,000. We were also active in the buyback market in Q2, executing about $184 million, retiring around 1.3 million shares. The net result of these activities in the quarter was a reduction of our share count our fully diluted shares outstanding in Q2 ended at just under 33 million shares, which is an all-time low share count since our IPO. On July 20, the Board of Directors authorized an incremental $100 million purchase of the company's common stock, bringing the total amount authorized through the end of 2023 to $116 million. At this point in time, we have fully deployed the excess capital of the company from the divestiture of our I&A business 2 years ago and we are in a normalized pattern for capital deployment. To partially fund these various cash outlays in Q2, we drew $80 million from our revolving credit facility, and we also renewed the facility with the existing banking syndicate for a new 5-year term. Overall, the balance sheet remains very healthy, and we have ample financial capacity to execute the business strategy. Before I turn the call back over to Matt, I will cover guidance for the third quarter. As Matt indicated in his opening comments. Over the past several weeks, we have experienced very low levels of bookings. This has impacted both of our business units. Accordingly, we are guiding revenue for the third quarter in the range of $190 million to $210 million, and we expect both business units to decline in Q3. Given the uncertainty in this market environment, we are temporarily expanding the range to plus/minus $10 million from the midpoint. We expect non-GAAP gross margin to be slightly higher in the third quarter at 59%. We are taking additional interim steps to control our OpEx in the third quarter. Accordingly, we are expecting non-GAAP operating expenses in the third quarter to decline to $95 million. We expect the non-GAAP effective tax rate to be approximately 23% in the third quarter. The lower tax rate includes a onetime discrete benefit of approximately $3 million related to a pronouncement from the IRS last week, delaying the effectiveness of certain unfavorable rules related to foreign tax credits. Our non-GAAP earnings per share is expected to be in the range of $0.45 to $0.73. On a GAAP basis, we expect gross margin to be 59%. We expect GAAP operating expenses to be approximately $120 million, and we expect GAAP rates per share to be between a loss of $0.08 and $0.20 income per share. I will now turn the call back over to Matt. Matt?